Growing evidence has shown that MMPs, especially MMP9, may contribute to cognitive impairment in neurodegenerative diseases through their involvement in blood-brain barrier (BBB) disruption30, a major driving factor for cognitive aging. Here, MMP9 is linked to neurodegenerative disease.